Chemoinformaics analysis of (11E,13R)-Labda-11,14-Diene-8,13-Diol
| Molecular Weight | 306.49 | nRot | 3 |
| Heavy Atom Molecular Weight | 272.218 | nRig | 13 |
| Exact Molecular Weight | 306.256 | nRing | 2 |
| Solubility: LogS | -5.042 | nHRing | 0 |
| Solubility: LogP | 4.079 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 57.675 |
| nHD | 2 | BPOL | 34.109 |
| QED | 0.755 |
| Synth | 4.659 |
| Natural Product Likeliness | 2.882 |
| NR-PPAR-gamma | 0.033 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.484 |
| Pgp-sub | 0.001 |
| HIA | 0.015 |
| CACO-2 | -4.42 |
| MDCK | 0.00002 |
| BBB | 0.295 |
| PPB | 0.869542 |
| VDSS | 1.196 |
| FU | 0.0640989 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.295 |
| CYP2c19-inh | 0.261 |
| CYP2c19-sub | 0.792 |
| CYP2c9-inh | 0.29 |
| CYP2c9-sub | 0.449 |
| CYP2d6-inh | 0.131 |
| CYP2d6-sub | 0.108 |
| CYP3a4-inh | 0.916 |
| CYP3a4-sub | 0.552 |
| CL | 3.317 |
| T12 | 0.265 |
| hERG | 0.031 |
| Ames | 0.004 |
| ROA | 0.383 |
| SkinSen | 0.523 |
| Carcinogencity | 0.047 |
| EI | 0.497 |
| Respiratory | 0.914 |
| NR-Aromatase | 0.235 |
| Antiviral | No |
| Prediction | 0.511084 |